Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics

During a disease outbreak/pandemic situation such as COVID-19, researchers are in a prime position to identify and develop peptide-based therapies, which could be more rapidly and cost-effectively advanced into a clinical setting. One drawback of natural peptide drugs, however, is their proteolytic...

Descripción completa

Detalles Bibliográficos
Autores principales: VanPatten, Sonya, He, Mingzhu, Altiti, Ahmad, F Cheng, Kai, Ghanem, Mustafa H, Al-Abed, Yousef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Newlands Press Ltd 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364852/
https://www.ncbi.nlm.nih.gov/pubmed/32672061
http://dx.doi.org/10.4155/fmc-2020-0180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364852/
https://www.ncbi.nlm.nih.gov/pubmed/32672061
http://dx.doi.org/10.4155/fmc-2020-0180

Ejemplares similares